 Connection
Stephen Humphries to Disease Progression
This is a "connection" page, showing publications Stephen Humphries has written about Disease Progression.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.830 |
|
|
|
-
Humphries SM, Chung A, Swigris JJ, Oh AS, Walsh SLF, Lynch DA, Goldin JG, Kim GHJ. Quantification of Interstitial Lung Diseases, From the AJR Special Series on Quantitative Imaging. AJR Am J Roentgenol. 2025 12; 225(6):e2432053.
Score: 0.131
-
Salisbury ML, Markin C, Fadely T, Guttentag AR, Humphries SM, Lynch DA, Kropski JA, Blackwell TS. Progressive Early Interstitial Lung Abnormalities in Persons at Risk for Familial Pulmonary Fibrosis: A Prospective Cohort Study. Am J Respir Crit Care Med. 2024 12 15; 210(12):1441-1452.
Score: 0.123
-
Humphries SM, Adegunsoye A, Demoruelle MK, Wei Kam ML, Amigues I, Bang TJ, Teague SD, Lynch DA, Chung JH, Strek ME, Swigris JJ, Solomon JJ. Quantitative CT Scan Analysis in Rheumatoid Arthritis-Related Interstitial Lung Disease. Chest. 2025 May; 167(5):1428-1439.
Score: 0.122
-
Mackintosh JA, Walsh SLF, Silva M, Calandriello L, Humphries SM, Lynch DA, Jo HE, Glaspole I, Grainge C, Goh N, Hopkins PMA, Moodley Y, Reynolds PN, Zappala C, Keir G, Cooper WA, Mahar AM, Ellis S, Wells AU, Corte TJ. Likelihood of Usual Interstitial Pneumonia: A Novel Approach to Prognosis for Pulmonary Fibrosis. Respirology. 2026 05; 31(5):521-529.
Score: 0.033
-
Guiot J, Engelberts J, Henket M, Ernst B, Maloir Q, Louis R, Lynch DA, Humphries SM, Charbonnier JP. Fibrotic and vascular abnormalities quantified by an AI-based model are associated with outcomes in patients with idiopathic pulmonary fibrosis. BMC Pulm Med. 2025 Oct 24; 25(1):488.
Score: 0.033
-
Putman RK, Rose JA, San José Estepar R, Tukpah AC, Cutting CC, Hino T, Hata A, Nishino M, Humphries SM, Lynch DA, Silverman EK, Cho MH, Rosas IO, Washko GR, Hatabu H, San José Estepar R, Hunninghake GM. Visual and Quantitative Interstitial Lung Abnormality Progression in COPDGene. Am J Respir Crit Care Med. 2025 10; 211(10):1794-1801.
Score: 0.032
-
Bhatt SP, Abadi E, Anzueto A, Bodduluri S, Casaburi R, Castaldi PJ, Cho MH, Comellas AP, Conrad DJ, Curtis JL, Dass C, DeMeo DL, Dransfield MT, San José Estépar R, Flenaugh EL, Foreman MG, Fortis S, Gupta A, Han MK, Hanania NA, Hersh CP, Hokanson JE, Humphries SM, Kirby M, Kunisaki KM, Li PZ, Lynch DA, MacIntyre NR, Make BJ, Mannino DM, Martinez FJ, McEvoy CE, Miller BE, Moll M, Nakhmani A, Newell JD, Pratte KA, Regan EA, Reinhardt JM, Rennard SI, Rossiter HB, Strand MJ, Suri R, Wan ES, Wendt CH, Westney GE, Wilson CG, Wise RA, Young KA, Tan WC, Silverman EK, Crapo JD. A Multidimensional Diagnostic Approach for Chronic Obstructive Pulmonary Disease. JAMA. 2025 06 24; 333(24):2164-2175.
Score: 0.032
-
San José Estépar R, Barr RG, Fain SB, Grenier PA, Hoffman EA, Humphries SM, Kirby M, Obuchowski N, Ryerson CJ, Seo JB, Tal-Singer R, Ash SY, Bankier AA, Crapo J, Han MK, Kellermeyer L, Goldin J, McCollough CH, Newell JD, Miller BE, Nordenmark LH, Remy-Jardin M, Prokop M, Ohno Y, Silverman EK, Strange C, Washko GR, Lynch DA. The Use of Computed Tomography Densitometry for the Assessment of Emphysema in Clinical Trials: A Position Paper from the Fleischner Society. Am J Respir Crit Care Med. 2025 05; 211(5):709-728.
Score: 0.031
-
Castaldi PJ, Xu Z, Young KA, Hokanson JE, Lynch DA, Humphries SM, Ross JC, Cho MH, Hersh CP, Crapo JD, Strand M, Silverman EK. Heterogeneity and Progression of Chronic Obstructive Pulmonary Disease: Emphysema-Predominant and Non-Emphysema-Predominant Disease. Am J Epidemiol. 2023 10 10; 192(10):1647-1658.
Score: 0.028
-
Denton CP, Goh NS, Humphries SM, Maher TM, Spiera R, Devaraj A, Ho L, Stock C, Erhardt E, Alves M, Wells AU. Extent of fibrosis and lung function decline in patients with systemic sclerosis and interstitial lung disease: data from the SENSCIS trial. Rheumatology (Oxford). 2023 05 02; 62(5):1870-1876.
Score: 0.027
-
Baraghoshi D, Strand M, Humphries SM, San José Estépar R, Vegas Sanchez-Ferrero G, Charbonnier JP, Latisenko R, Silverman EK, Crapo JD, Lynch DA. Quantitative CT Evaluation of Emphysema Progression over 10 Years in the COPDGene Study. Radiology. 2023 05; 307(4):e222786.
Score: 0.027
-
Fernández Pérez ER, Crooks JL, Lynch DA, Humphries SM, Koelsch TL, Swigris JJ, Solomon JJ, Mohning MP, Groshong SD, Fier K. Pirfenidone in fibrotic hypersensitivity pneumonitis: a double-blind, randomised clinical trial of efficacy and safety. Thorax. 2023 11; 78(11):1097-1104.
Score: 0.027
-
Redente EF, Black BP, Backos DS, Bahadur AN, Humphries SM, Lynch DA, Tuder RM, Zemans RL, Riches DWH. Persistent, Progressive Pulmonary Fibrosis and Epithelial Remodeling in Mice. Am J Respir Cell Mol Biol. 2021 06; 64(6):669-676.
Score: 0.024
-
Tejwani V, Fawzy A, Putcha N, Castaldi PJ, Cho MH, Pratte KA, Bhatt SP, Lynch DA, Humphries SM, Kinney GL, D'Alessio FR, Hansel NN. Emphysema Progression and Lung Function Decline Among Angiotensin Converting Enzyme Inhibitors and Angiotensin-Receptor Blockade Users in the COPDGene Cohort. Chest. 2021 10; 160(4):1245-1254.
Score: 0.024
-
Ash SY, San José Estépar R, Fain SB, Tal-Singer R, Stockley RA, Nordenmark LH, Rennard S, Han MK, Merrill D, Humphries SM, Diaz AA, Mason SE, Rahaghi FN, Pistenmaa CL, Sciurba FC, Vegas-Sánchez-Ferrero G, Lynch DA, Washko GR. Relationship between Emphysema Progression at CT and Mortality in Ever-Smokers: Results from the COPDGene and ECLIPSE Cohorts. Radiology. 2021 04; 299(1):222-231.
Score: 0.024
-
El Kaddouri B, Strand MJ, Baraghoshi D, Humphries SM, Charbonnier JP, van Rikxoort EM, Lynch DA. Fleischner Society Visual Emphysema CT Patterns Help Predict Progression of Emphysema in Current and Former Smokers: Results from the COPDGene Study. Radiology. 2021 02; 298(2):441-449.
Score: 0.023
-
Oh AS, Strand M, Pratte K, Regan EA, Humphries S, Crapo JD, Lynch DA. Visual Emphysema at Chest CT in GOLD Stage 0 Cigarette Smokers Predicts Disease Progression: Results from the COPDGene Study. Radiology. 2020 09; 296(3):641-649.
Score: 0.023
-
Salisbury ML, Hewlett JC, Ding G, Markin CR, Douglas K, Mason W, Guttentag A, Phillips JA, Cogan JD, Reiss S, Mitchell DB, Wu P, Young LR, Lancaster LH, Loyd JE, Humphries SM, Lynch DA, Kropski JA, Blackwell TS. Development and Progression of Radiologic Abnormalities in Individuals at Risk for Familial Interstitial Lung Disease. Am J Respir Crit Care Med. 2020 05 15; 201(10):1230-1239.
Score: 0.022
-
Pompe E, Strand M, van Rikxoort EM, Hoffman EA, Barr RG, Charbonnier JP, Humphries S, Han MK, Hokanson JE, Make BJ, Regan EA, Silverman EK, Crapo JD, Lynch DA. Five-year Progression of Emphysema and Air Trapping at CT in Smokers with and Those without Chronic Obstructive Pulmonary Disease: Results from the COPDGene Study. Radiology. 2020 04; 295(1):218-226.
Score: 0.022
-
Raghu G, Ley B, Brown KK, Cottin V, Gibson KF, Kaner RJ, Lederer DJ, Noble PW, Song JW, Wells AU, Whelan TP, Lynch DA, Humphries SM, Moreau E, Goodman K, Patterson SD, Smith V, Gong Q, Sundy JS, O'Riordan TG, Martinez FJ. Risk factors for disease progression in idiopathic pulmonary fibrosis. Thorax. 2020 01; 75(1):78-80.
Score: 0.021
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|